marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
CytomX Therapeutics Cash Flow 2011-2024 | CTMX
Annual Cash Flow CytomX Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-56 M | -111 M | -119 M | 5.26 M | -140 M | -75.5 M | 170 M | -2.03 M | - | - | - | - | - |
Depreciation & Amortization |
2 M | 2.3 M | 2.6 M | 2.4 M | 2.5 M | 1.88 M | 1.64 M | 1.73 M | 1.21 M | 783 K | 655 K | - | - |
Accounts Payables |
1.46 M | 2.81 M | 2.82 M | 3 M | 4.16 M | 5.13 M | 4.2 M | 6.6 M | 4.7 M | - | - | - | - |
Accounts Receivables |
3.43 M | 36 M | 790 K | 798 K | 13 K | 97 K | 10.1 M | 2.16 M | 744 K | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow CytomX Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -26 M | - | - | 9.35 M | - | -109 M | - | -41.3 M | - | -87.8 M | - | -29.9 M | - | 22.7 M | 47.4 M | -49.7 M | - | -111 M | -87.7 M | -39 M | - | -46.8 M | -41.2 M | -14.6 M | - | 148 M | 154 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 36 K | - | - | 36 K | - | 110 K | - | 37 K | - | 110 K | - | 36 K | - | 109 K | 72 K | 36 K | - | 109 K | 73 K | 617 K | - | 109 K | 802 K | 376 K | - | 1.24 M | 369 K | 395 K | - | 443 K | 445 K | 355 K | - | 307 K | 302 K | 268 K | - | 562 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
1.42 M | 611 K | 1.96 M | 1.7 M | 1.03 M | 2.2 M | 2.81 M | 5.18 M | - | 1.72 M | 2.82 M | 1.52 M | 1.76 M | 2.58 M | 3 M | 3 M | 3 M | 3 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 1.92 M | 1.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
3.35 M | 2.78 M | 13.2 M | 2.42 M | 1.9 M | 1.09 M | 36 M | 1.71 M | - | 1.02 M | 790 K | 887 K | 931 K | 756 K | 798 K | 798 K | 798 K | 798 K | 13 K | 13 K | 13 K | 13 K | 97 K | 97 K | 97 K | 97 K | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 2.16 M | 2.16 M | 2.16 M | 2.16 M | 372 K | 372 K | 372 K | 372 K | 1.88 M | 1.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency